1190265

Aesica Pharmaceutical GmbH — FEI 3002943189

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
July 1, 2021
Fiscal Year
2021
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Monheim am Rhein (Germany)

Additional Details

Mutual Recognition Agreement (MRA)